MARKET

AVDL

AVDL

Avadel Pharmaceu
NASDAQ
13.84
+0.52
+3.90%
After Hours: 13.63 -0.21 -1.52% 19:49 05/26 EDT
OPEN
13.32
PREV CLOSE
13.32
HIGH
14.15
LOW
13.32
VOLUME
388.09K
TURNOVER
0
52 WEEK HIGH
15.82
52 WEEK LOW
1.050
MARKET CAP
1.06B
P/E (TTM)
-5.9356
1D
5D
1M
3M
1Y
5Y
Avadel Pharmaceu: Statement of changes in beneficial ownership of securities
Press release · 05/20 19:04
Insider Buy: Avadel Pharmaceuticals
Insider Buy: Avadel Pharmaceuticals
MT Newswires · 05/19 16:36
Avadel Pharmaceuticals: Lumryz Approved, Launch Expected June 2023 And We Remain Bullish
Seeking Alpha · 05/17 06:56
Why Shares of Avadel Soared This Week
Motley Fool · 05/05 19:44
SVB Securities Sticks to Its Buy Rating for Avadel Pharmaceuticals (AVDL)
TipRanks · 05/05 15:15
Avadel Pharmaceuticals Q1 EPS $(0.48) Down From $(0.45) YoY
Benzinga · 05/04 21:22
Avadel Pharmaceuticals GAAP EPS of -$0.48 misses by $0.10
Seeking Alpha · 05/04 21:19
Avadel Pharmaceuticals' Strategic Moves To Conquer The Narcolepsy Market (Rating Upgrade)
Seeking Alpha · 05/03 18:00
More
About AVDL
Avadel Pharmaceuticals plc is a biopharmaceutical company. The Company's lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy. Its drug delivery technologies include Micropump, LiquiTime, and Medusa. Its Micropump drug-delivery technology allows for the controlled delivery of small molecule drugs taken orally, which improves dosing compliance, reduces toxicity and improves patient compliance. Its LiquiTime technology allows for development of modified release oral products in a liquid suspension formulation, which makes such formulations particularly well suited for children and/or patients having issues swallowing tablets or capsules. Its Medusa technology allows for the development of modified-release-injectable dosage formulations of drugs, such as peptides, polypeptides, proteins, and small molecules.

Webull offers kinds of Avadel Pharmaceuticals PLC (ADR) stock information, including NASDAQ:AVDL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVDL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVDL stock methods without spending real money on the virtual paper trading platform.